Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.
Office of Infection Control, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.
J Diabetes Res. 2019 Feb 17;2019:8151836. doi: 10.1155/2019/8151836. eCollection 2019.
Diabetes aggravates myocardial ischemia-reperfusion (I/R) injury because of the combination effects of changes in glucose and lipid energy metabolism, oxidative stress, and systemic inflammatory response. Studies have indicated that myocardial I/R may coincide and interact with sepsis and inflammation. However, the role of LPS in hypoxia/reoxygenation (H/R) injury in cardiomyocytes under high glucose conditions is still unclear. Our objective was to examine whether lipopolysaccharide (LPS) could aggravate high glucose- (HG-) and hypoxia/reoxygenation- (H/R-) induced injury by upregulating ROS production to activate NLRP3 inflammasome-mediated pyroptosis in H9C2 cardiomyocytes. H9C2 cardiomyocytes were exposed to HG (30 mM) condition with or without LPS, along with caspase-1 inhibitor (Ac-YVAD-CMK), inflammasome inhibitor (BAY11-7082), ROS scavenger N-acetylcysteine (NAC), or not for 24 h, then subjected to 4 h of hypoxia followed by 2 h of reoxygenation (H/R). The cell viability, lactate dehydrogenase (LDH) release, caspase-1 activity, and intracellular ROS production were detected by using assay kits. The incidence of pyroptosis was detected by calcein-AM/propidium iodide (PI) double staining kit. The concentrations of IL-1 and IL-18 in the supernatants were assessed by ELISA. The mRNA levels of NLRP3, ASC, and caspase-1 were detected by qRT-PCR. The protein levels of NF-B p65, NLRP3, ASC, cleaved caspase-1 (p10), IL-1, and IL-18 were detected by western blot. The results indicated that pretreatment LPS with 1 g/ml not 0.1 g/ml could efficiently aggravate HG and H/R injury by activating NLRP3 inflammasome to mediate pyroptosis in H9C2 cells, as evidenced by increased LDH release and decreased cell viability in the cells, and increased expression of NLRP3, ASC, cleaved caspase-1 (p10), IL-1, and IL-18. Meanwhile, Ac-YVAD-CMK, BAY11-7082, or NAC attenuated HG- and H/R-induced H9C2 cell injury with LPS stimulated by reversing the activation of NLRP3 inflammasome-mediated pyroptosis. In conclusion, LPS could increase the sensitivity of H9C2 cells to HG and H/R and aggravated HG- and H/R-induced H9C2 cell injury by promoting ROS production to induce NLRP3 inflammasome-mediated pyroptosis.
糖尿病会加重心肌缺血再灌注(I/R)损伤,这是由于葡萄糖和脂质能量代谢变化、氧化应激和全身炎症反应的综合作用。研究表明,心肌 I/R 可能与脓毒症和炎症同时发生并相互作用。然而,脂多糖(LPS)在高糖条件下缺氧/复氧(H/R)诱导的心肌细胞损伤中的作用尚不清楚。我们的目的是研究 LPS 是否可以通过增加 ROS 产生来激活 NLRP3 炎性体介导热激细胞死亡,从而加重高糖(HG)和缺氧/复氧(H/R)诱导的损伤,在 H9C2 心肌细胞中。将 H9C2 心肌细胞暴露于 HG(30 mM)条件下,有或没有 LPS,同时使用 caspase-1 抑制剂(Ac-YVAD-CMK)、炎性体抑制剂(BAY11-7082)、ROS 清除剂 N-乙酰半胱氨酸(NAC)或不进行 24 小时处理,然后进行 4 小时缺氧,随后进行 2 小时复氧(H/R)。通过测定试剂盒检测细胞活力、乳酸脱氢酶(LDH)释放、caspase-1 活性和细胞内 ROS 产生。通过 calcein-AM/碘化丙啶(PI)双重染色试剂盒检测细胞焦亡的发生率。通过 ELISA 测定上清液中 IL-1 和 IL-18 的浓度。通过 qRT-PCR 检测 NLRP3、ASC 和 caspase-1 的 mRNA 水平。通过 Western blot 检测 NF-B p65、NLRP3、ASC、裂解的 caspase-1(p10)、IL-1 和 IL-18 的蛋白水平。结果表明,用 1 g/ml 的 LPS 预处理(而不是 0.1 g/ml)可以通过激活 NLRP3 炎性体来介导 H9C2 细胞中的细胞焦亡,从而有效加重 HG 和 H/R 损伤,这表现在细胞中 LDH 释放和细胞活力降低,以及 NLRP3、ASC、裂解的 caspase-1(p10)、IL-1 和 IL-18 的表达增加。同时,Ac-YVAD-CMK、BAY11-7082 或 NAC 通过逆转 LPS 刺激的 NLRP3 炎性体介导热激细胞死亡的激活,减轻了 HG 和 H/R 诱导的 H9C2 细胞损伤。总之,LPS 可以通过增加 ROS 产生来诱导 NLRP3 炎性体介导热激细胞死亡,从而增加 H9C2 细胞对 HG 和 H/R 的敏感性,并加重 HG 和 H/R 诱导的 H9C2 细胞损伤。